Reliability, Validity and Factorial Structure of the Arabic Version of the International Suicide Prevention Trial (InterSePT) Scale for Suicidal Thinking in Schizophrenia Patients in Doha, Qatar

Overview

Journal BMC Psychiatry

Publisher Biomed Central

Specialty Psychiatry

Date 2016 Dec 9

PMID 27927173

Citations 3

Authors

Samer Hammoudeh

Suhaila Ghuloum

Ziyad Mahfoud

Mark Opler

Anzalee Khan

Arij Yehya

Abdulmoneim Abdulhakam

Azza Al-Mujalli

Yahya Hani

Reem Elsherbiny

Hassen Al-Amin

Affiliations

Soon will be listed here.

Abstract

Background: Patients with schizophrenia are known to have higher rates of mortality and morbidity when compared to the general population. Suicidality is a major contributor to increased mortality. The International Suicide Prevention Trial (InterSePT) Scale for Suicidal Thinking (ISST) is a validated tool to assess current suicidal ideation in patients with schizophrenia. The aims of the study were to culturally adapt the Arabic translation of ISST and to examine the psychometric characteristics of the Arabic version of the ISST among patients with schizophrenia in Qatar.

Methods: ISST was translated and adapted into formal Arabic using the back translation method. Patients diagnosed with schizophrenia were randomly recruited from the department of Psychiatry, Rumailah Hospital, Doha, Qatar. Healthy controls were randomly recruited from two primary health care centers in Doha, Qatar. The Arabic version of Module B for suicidality in Mini International Neuropsychiatric Interview was used as the gold standard to which the Arabic ISST was compared.

Results: The study sample (n = 199) was composed of 100 patients diagnosed with schizophrenia (age 35.30 ± 10.04 years; M/F is 2/1) and 99 controls (age 33.98 ± 8.33 years; M/F is 2/3). The mean score on the ISST was 3.03 ± 4.75 vs. 0.47 ± 1.44 for the schizophrenia and control groups, respectively. Inter-rater reliability coefficient was 0.95, p > 0.001. The overall Cronbach's alpha was 0.92. Principal Component Analysis produced 3 factors explaining a total of 73.8% of variance.

Conclusions: This is the first study in the Arab countries to validate the Arabic version of the ISST. The psychometric properties indicate that the Arabic ISST is a valid tool to assess the severity of suicidal ideation in Arabic patients with schizophrenia.

Citing Articles

Association of empathy with clinical symptoms and cognitive function in chronic schizophrenia patients with and without suicide attempts.

Ma Z, Tian Y, Li J, Liu J, Wang D, Zhang X Eur Arch Psychiatry Clin Neurosci. 2024; 274(6):1395-1404.

PMID: 38478155 DOI: 10.1007/s00406-024-01785-0.

Thematic analysis of the raters' experiences administering scales to assess depression and suicide in Arab schizophrenia patients.

Amro I, Ghuloum S, Hammoudeh S, Hani Y, Yehya A, Al-Amin H BMC Psychiatry. 2022; 22(1):652.

PMID: 36271342 PMC: 9587575. DOI: 10.1186/s12888-022-04313-3.

Self-Reported Sleep and Exercise Patterns in Patients with Schizophrenia: a Cross-Sectional Comparative Study.

Kiwan N, Mahfoud Z, Ghuloum S, Chamali R, Yehya A, Hammoudeh S Int J Behav Med. 2019; 27(4):366-377.

PMID: 31848893 PMC: 7359133. DOI: 10.1007/s12529-019-09830-2.

References

Kadri N, Agoub M, El Gnaoui S, Alami K, Hergueta T, Moussaoui D . Moroccan colloquial Arabic version of the Mini International Neuropsychiatric Interview (MINI): qualitative and quantitative validation. Eur Psychiatry. 2005; 20(2):193-5. DOI: 10.1016/j.eurpsy.2004.11.007. View

Palmer B, Pankratz V, Bostwick J . The lifetime risk of suicide in schizophrenia: a reexamination. Arch Gen Psychiatry. 2005; 62(3):247-53. DOI: 10.1001/archpsyc.62.3.247. View

Hawton K, Sutton L, Haw C, Sinclair J, Deeks J . Schizophrenia and suicide: systematic review of risk factors. Br J Psychiatry. 2005; 187:9-20. DOI: 10.1192/bjp.187.1.9. View

Preti A, Sheehan D, Coric V, Distinto M, Pitanti M, Vacca I . Sheehan Suicidality Tracking Scale (S-STS): reliability, convergent and discriminative validity in young Italian adults. Compr Psychiatry. 2013; 54(7):842-9. DOI: 10.1016/j.comppsych.2013.03.012. View

Preston E, Hansen L . A systematic review of suicide rating scales in schizophrenia. Crisis. 2006; 26(4):170-80. DOI: 10.1027/0227-5910.26.4.170. View

Taiminen T, Huttunen J, Heila H, Henriksson M, Isometsa E, Kahkonen J . The Schizophrenia Suicide Risk Scale (SSRS): development and initial validation. Schizophr Res. 2001; 47(2-3):199-213. DOI: 10.1016/s0920-9964(00)00126-2. View

Bertelsen M, Jeppesen P, Petersen L, Thorup A, Ohlenschlaeger J, le Quach P . Suicidal behaviour and mortality in first-episode psychosis: the OPUS trial. Br J Psychiatry Suppl. 2008; 51:s140-6. DOI: 10.1192/bjp.191.51.s140. View

Nock M, Hwang I, Sampson N, Kessler R, Angermeyer M, Beautrais A . Cross-national analysis of the associations among mental disorders and suicidal behavior: findings from the WHO World Mental Health Surveys. PLoS Med. 2009; 6(8):e1000123. PMC: 2717212. DOI: 10.1371/journal.pmed.1000123. View

Alphs L, Anand R, Islam M, Meltzer H, Kane J, Krishnan R . The international suicide prevention trial (interSePT): rationale and design of a trial comparing the relative ability of clozapine and olanzapine to reduce suicidal behavior in schizophrenia and schizoaffective patients. Schizophr Bull. 2005; 30(3):577-86. DOI: 10.1093/oxfordjournals.schbul.a007102. View

10.

Meltzer H, Baldessarini R . Reducing the risk for suicide in schizophrenia and affective disorders. J Clin Psychiatry. 2003; 64(9):1122-9. DOI: 10.4088/jcp.v64n0920. View

11.

Posner K, Brown G, Stanley B, Brent D, Yershova K, Oquendo M . The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults. Am J Psychiatry. 2011; 168(12):1266-77. PMC: 3893686. DOI: 10.1176/appi.ajp.2011.10111704. View

12.

Croxtall J . Aripiprazole: a review of its use in the management of schizophrenia in adults. CNS Drugs. 2012; 26(2):155-83. DOI: 10.2165/11208400-000000000-00000. View

13.

Osman A, Gutierrez P, Kopper B, Barrios F, Chiros C . The positive and negative suicide ideation inventory: development and validation. Psychol Rep. 1998; 82(3 Pt 1):783-93. DOI: 10.2466/pr0.1998.82.3.783. View

14.

McGrath J, Saha S, Welham J, El Saadi O, MacCauley C, Chant D . A systematic review of the incidence of schizophrenia: the distribution of rates and the influence of sex, urbanicity, migrant status and methodology. BMC Med. 2004; 2:13. PMC: 421751. DOI: 10.1186/1741-7015-2-13. View

15.

Hor K, Taylor M . Suicide and schizophrenia: a systematic review of rates and risk factors. J Psychopharmacol. 2010; 24(4 Suppl):81-90. PMC: 2951591. DOI: 10.1177/1359786810385490. View

16.

Reutfors J, Brandt L, Jonsson E, Ekbom A, Sparen P, Osby U . Risk factors for suicide in schizophrenia: findings from a Swedish population-based case-control study. Schizophr Res. 2009; 108(1-3):231-7. DOI: 10.1016/j.schres.2008.12.023. View

17.

Ayer D, Jayathilake K, Meltzer H . The InterSePT suicide scale for prediction of imminent suicidal behaviors. Psychiatry Res. 2008; 161(1):87-96. DOI: 10.1016/j.psychres.2007.07.029. View

18.

Lindenmayer J, Czobor P, Alphs L, Nathan A, Anand R, Islam Z . The InterSePT scale for suicidal thinking reliability and validity. Schizophr Res. 2003; 63(1-2):161-70. DOI: 10.1016/s0920-9964(02)00335-3. View

19.

Saha S, Chant D, Welham J, McGrath J . A systematic review of the prevalence of schizophrenia. PLoS Med. 2005; 2(5):e141. PMC: 1140952. DOI: 10.1371/journal.pmed.0020141. View

20.

Montross L, Zisook S, Kasckow J . Suicide among patients with schizophrenia: a consideration of risk and protective factors. Ann Clin Psychiatry. 2006; 17(3):173-82. DOI: 10.1080/10401230591002156. View